0001144204-16-113555.txt : 20160719 0001144204-16-113555.hdr.sgml : 20160719 20160719160532 ACCESSION NUMBER: 0001144204-16-113555 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160719 FILED AS OF DATE: 20160719 DATE AS OF CHANGE: 20160719 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALCOBRA LTD. CENTRAL INDEX KEY: 0001566049 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1213 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35932 FILM NUMBER: 161773570 BUSINESS ADDRESS: STREET 1: AZRIELI TRIANGLE BUILDING STREET 2: 132 DERECH MENACHEM BEGIN, 39TH FLOOR CITY: TEL AVIV STATE: L3 ZIP: 6701101 BUSINESS PHONE: 972722204661 MAIL ADDRESS: STREET 1: AZRIELI TRIANGLE BUILDING STREET 2: 132 DERECH MENACHEM BEGIN, 39TH FLOOR CITY: TEL AVIV STATE: L3 ZIP: 6701101 6-K 1 v444488_6k.htm FORM 6-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of: July 2016 (Report No. 2)

Commission file number: 001-35932

ALCOBRA LTD.

(Translation of registrant's name into English)

Azrieli Triangle Building

132 Derech Menachem Begin 39th Floor

Tel Aviv 6701101 Israel

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(1):_____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulations S-T Rule 101(b)(7):_____

Results of the Annual General Meeting of Shareholders

At the annual general meeting of shareholders held on July 19, 2016, the shareholders of Alcobra Ltd. approved all agenda items as originally proposed.

This Form 6-K is incorporated by reference into the Registration Statements on Form F-3 (File No. 333- 209960) and Form S-8 (File No. 333-194875, 333-202394 and 333-209947) of the Registrant, filed with the Securities and Exchange Commission, to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Alcobra Ltd.
	(Registrant)


	By /s/ Dr. Tomer Berkovitz

	Name: Dr. Tomer Berkovitz

	Chief Financial Officer and Chief Operating Officer

Date: July 19, 2016